As of 2024-12-13, the Relative Valuation of Biogen Inc (BIIB) is 278.03 USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.33 USD, the upside of Biogen Inc based on Relative Valuation is 79.0%.
The range of the Relative Valuation is 192.12 - 345.16 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 31.1x | 26.4x |
| Forward P/E multiples | 24.3x - 42.1x | 33.2x |
| Fair Price | 192.12 - 345.16 | 278.03 |
| Upside | 23.7% - 122.2% | 79.0% |
| Date | P/E |
| 2024-12-12 | 14.01 |
| 2024-12-11 | 14.21 |
| 2024-12-10 | 14.10 |
| 2024-12-09 | 14.12 |
| 2024-12-06 | 14.23 |
| 2024-12-05 | 14.37 |
| 2024-12-04 | 14.52 |
| 2024-12-03 | 14.51 |
| 2024-12-02 | 14.82 |
| 2024-11-29 | 14.49 |
| 2024-11-27 | 14.42 |
| 2024-11-26 | 14.23 |
| 2024-11-25 | 14.32 |
| 2024-11-22 | 14.25 |
| 2024-11-21 | 14.26 |
| 2024-11-20 | 14.07 |
| 2024-11-19 | 14.02 |
| 2024-11-18 | 14.25 |
| 2024-11-15 | 14.43 |
| 2024-11-14 | 14.88 |
| 2024-11-13 | 14.96 |
| 2024-11-12 | 15.18 |
| 2024-11-11 | 15.52 |
| 2024-11-08 | 15.61 |
| 2024-11-07 | 15.69 |
| 2024-11-06 | 15.73 |
| 2024-11-05 | 15.96 |
| 2024-11-04 | 15.65 |
| 2024-11-01 | 15.68 |
| 2024-10-31 | 15.70 |
| 2024-10-30 | 16.35 |
| 2024-10-29 | 16.55 |
| 2024-10-28 | 16.69 |
| 2024-10-25 | 16.39 |
| 2024-10-24 | 16.59 |
| 2024-10-23 | 16.51 |
| 2024-10-22 | 16.77 |
| 2024-10-21 | 16.66 |
| 2024-10-18 | 17.16 |
| 2024-10-17 | 17.10 |
| 2024-10-16 | 17.05 |
| 2024-10-15 | 17.28 |
| 2024-10-14 | 17.28 |
| 2024-10-11 | 17.00 |
| 2024-10-10 | 17.01 |
| 2024-10-09 | 16.76 |
| 2024-10-08 | 16.45 |
| 2024-10-07 | 16.54 |
| 2024-10-04 | 16.75 |
| 2024-10-03 | 16.67 |